| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: RGDX |
| Security Type |
Common Stock |
| Lead Underwriter |
Maxim Group LLC |
| Days In Registration |
165 |
| Date Filed |
21-Dec-2006 |
| Form Filed | S-B2 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Response Genetics Inc, located in Los Angeles, California, provides research services for the development of pharmacogenic diagnostic tests, gene expression analysis, molecular diagnostics, research consulting, and bioinformatics. It offers services to the pharmaceutical industry for cancer in the United States, Europe, and Japan. The company was founded in 1999. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
10.24M |
| Contact |
- |
| Number of Employees |
50 |
|
| Original Filing Information |
| US |
| Shares Filed |
3.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
3.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
450.0K |
| File Amount |
$22.5M |
| File Price Range |
$8.00 - $7.00 |
| File Mid Price |
$7.50 |
Current Filing Information
(Amended 4-Jun-2007) |
|
US |
|
Shares Filed |
3.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
3.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$22.5M |
| · % Change from Original |
0.0 |
| File Price Range |
$8.00 - $7.00 |
| File Mid Price |
$7.50 |
|
